Tweets
Fautrel reports mixed response to JAK Inhib. in 8 refractory Adult (6) & juvenile (2)-Onset Still's Dz w/ dz Dz duration 86 mos (7 Systemic, 1 Chr articular) w/ JAKi (Bari 4, Upa1, Tofa 2, Ruxo 2). There were no remissions, 50% had partial response @ 11 mos #ACR21 Abstr#0195 https://t.co/Ww8ONBrRqq
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
RheumNow’s expanded coverage of the #ACR21 meeting is sponsored in part by @bmsnews, @JanssenUS, @Novartis. All content chosen by RheumNow & its Faculty.
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
#ACR21 #pedsrheum
With so much work ahead, what to tackle first?
1⃣Gathering and organizing the top 10 priorities in cSLE https://t.co/H3ASXAfM4m
Dr. Laura Lewandowski @LauraLewMad11 ( View Tweet )
4 years 9 months ago
Rheum Radiology Bootcamp
Rheum dz = increased risk of lung cancer
Important note: Fleischner recs for incidental nodules do not apply to immunosuppressed patients. Stay on alert for malignancy.
#ACR2021
Pedro Castillo @_Castillo_Pedro ( View Tweet )
4 years 9 months ago
Consider baseline risk of lung cancer. Scleroderma and RA in particular at increased risk => lower threshold for getting initial CT. For incidental nodule, consider rescreening at 6-12 months, then space out.
#ACR2021
Pedro Castillo @_Castillo_Pedro ( View Tweet )
4 years 9 months ago
Brepocitinib (TYK2/JAK1i) superior to PBO in PsA at week 16, w/ improvements in refractory domains continuing over 52 weeks. There were more AEs in the brepocitinib groups vs PBO over 16 weeks. Abs 0488 #ACR21 #RheumNow @RheumNow https://t.co/umk4REJwkS https://t.co/JYZVR3jyY5
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 9 months ago
BE AGILE: No new safety signals in AS pts treated with BKZ ( IL-17F/IL-17Ai) and remains efficacious as a potential treatment in AS. Abs 0491 #ACR21 #RheumNow @RheumNow https://t.co/fGT8n5Hx9C https://t.co/rjPTla7JId
Dr. Rachel Tate @uptoTate ( View Tweet )
4 years 9 months ago
Common sense to ⬇️#rheumatoidarthritis 6S412 G Burmester summarizes decades of RA research - avoidance strategies =healthy lifestyle. ?asked is sero+RA diff than seronegative? Maybe. other Abs likely exist @RheumNow #ACR21 #ACRBest https://t.co/RT3dHDfdWp
Janet Pope @Janetbirdope ( View Tweet )
4 years 9 months ago
After elegantly laying out the sophisticated science at #ACR21, Gerd Burmester finishes with this:
Without waiting, 11 things we can actually do now to reduce our chance of RA
@The_IMJ Ranjeny Thomas and @lynmarch1 et al
@RheumNow https://t.co/Be1Jyw9FOo
David Liew @drdavidliew ( View Tweet )
4 years 9 months ago
I'm wearing my badge, just in case... #RheumPix https://t.co/UvgCinq8Bn
Dr. John Cush @RheumNow ( View Tweet )
4 years 9 months ago
Spinal involvement: fine, symmetric syndesmophytes (axSpA) vs bulky, asymmetric syndesmophytes (axPsA)
#ACR21 https://t.co/7leGTjm4fb
Rheum Cat @rheum_cat ( View Tweet )
4 years 9 months ago
@AUGarren @DavidLeverenz demonstrate significant gaps in DMARD lab safety monitoring in telehealth setting. Small improvement over time but still <50% 😱 Abstr#0146 #ACR21 @RheumNow https://t.co/FDp7ZwzfO5
Richard Conway @RichardPAConway ( View Tweet )
4 years 9 months ago
